Yanan Cui

State Key Laboratory Of Bioreactor Engineering
Shanghai, 200237, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Enhanced heparosan biosynthesis in Corynebacterium glutamicum by systematic metabolic engineering and translation-level fine-tuning.

Enhanced heparosan biosynthesis in Corynebacterium glutamicum by systematic metabolic engineering and translation-level fine-tuning.

Journal: Bioresources and bioprocessing

Published: May 14, 2026

Multi-dimensional metabolic engineering and enzyme engineering in Escherichia coli for highly efficient biosynthesis of 2,5-furandicarboxylic acid.

Multi-dimensional metabolic engineering and enzyme engineering in Escherichia coli for highly efficient biosynthesis of 2,5-furandicarboxylic acid.

Journal: Bioresource technology

Published: April 06, 2026

Shifting Biological Drivers Govern Drought and Wetting Legacies on Soil Respiration.

Shifting Biological Drivers Govern Drought and Wetting Legacies on Soil Respiration.

Journal: Global change biology

Published: January 27, 2026

Isolation and Identification of a Novel Chitinilyticum sp.C8: Unleashing the Potential for Chitin Oligosaccharides Production.

Isolation and Identification of a Novel Chitinilyticum sp.C8: Unleashing the Potential for Chitin Oligosaccharides Production.

Journal: Journal of agricultural and food chemistry

Published: May 06, 2025

IFITM3 enhances immunosensitivity via MHC-I regulation and is associated with the efficacy of anti-PD-1/-L1 therapy in SCLC.

IFITM3 enhances immunosensitivity via MHC-I regulation and is associated with the efficacy of anti-PD-1/-L1 therapy in SCLC.

Journal: Molecular cancer

Published: March 13, 2025

Identification of gene signatures relevant to the efficacy of immune checkpoint inhibitors in non-small cell lung cancer.

Identification of gene signatures relevant to the efficacy of immune checkpoint inhibitors in non-small cell lung cancer.

Journal: Medicine

Published: December 10, 2024

Leveraging mitochondrial-programmed cell death dynamics to enhance prognostic accuracy and immunotherapy efficacy in lung adenocarcinoma.

Leveraging mitochondrial-programmed cell death dynamics to enhance prognostic accuracy and immunotherapy efficacy in lung adenocarcinoma.

Journal: Journal for immunotherapy of cancer

Published: October 07, 2024

Habitat radiomics analysis for progression free survival and immune-related adverse reaction prediction in non-small cell lung cancer treated by immunotherapy.

Habitat radiomics analysis for progression free survival and immune-related adverse reaction prediction in non-small cell lung cancer treated by immunotherapy.

Journal: Journal of translational medicine

Published: September 09, 2024

Peripheral NK cells identified as the predictor of response in extensive-stage small cell lung cancer patients treated with first-line immunotherapy plus chemotherapy.

Peripheral NK cells identified as the predictor of response in extensive-stage small cell lung cancer patients treated with first-line immunotherapy plus chemotherapy.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: February 09, 2024

Exploring cellular diversity in lung adenocarcinoma epithelium: Advancing prognostic methods and immunotherapeutic strategies.

Exploring cellular diversity in lung adenocarcinoma epithelium: Advancing prognostic methods and immunotherapeutic strategies.

Journal: Cell proliferation

Published: January 31, 2024

Concomitant genomic features stratify prognosis to patients with advanced EGFR mutant lung cancer.

Concomitant genomic features stratify prognosis to patients with advanced EGFR mutant lung cancer.

Journal: Molecular carcinogenesis

Published: December 25, 2023

An advanced NSCLC patient with ALK-RNF144A and HIP1-ALK fusions treated with ALK-TKI combination therapy: a case report.

An advanced NSCLC patient with ALK-RNF144A and HIP1-ALK fusions treated with ALK-TKI combination therapy: a case report.

Journal: Translational lung cancer research

Published: October 13, 2023

Showing 1-12 of 30

Last Updated: 09/26/2026